Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.

Miniaturization and parallel processing play an important role in the evolution of many technologies. We demonstrate the application of miniaturized high-throughput experimentation methods to resolve synthetic chemistry challenges on the frontlines of a lead optimization effort to develop diacylglycerol acyltransferase (DGAT1) inhibitors. Reactions were performed on ∼1 mg scale using glass microvials providing a miniaturized high-throughput experimentation capability that was used to study a challenging SNAr reaction. The availability of robust synthetic chemistry conditions discovered in these miniaturized investigations enabled the development of structure-activity relationships that ultimately led to the discovery of soluble, selective, and potent inhibitors of DGAT1.

[1]  P. Chirik,et al.  Cobalt Precursors for High-Throughput Discovery of Base Metal Asymmetric Alkene Hydrogenation Catalysts , 2013, Science.

[2]  G. Molander,et al.  Nickel-catalyzed cross-coupling of potassium aryl- and heteroaryltrifluoroborates with unactivated alkyl halides. , 2010, Organic letters.

[3]  Ian Hughes,et al.  Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm. , 2011, ACS medicinal chemistry letters.

[4]  Daniel M. Lowe,et al.  Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists' Bread and Butter. , 2016, Journal of medicinal chemistry.

[5]  Nidhal Selmi,et al.  Making medicinal chemistry more effective--application of Lean Sigma to improve processes, speed and quality. , 2009, Drug discovery today.

[6]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[7]  F. Glorius,et al.  The straight dope on the scope of chemical reactions , 2016, Science.

[8]  Chelsea A. Huff,et al.  Photoredox-Catalyzed Hydroxymethylation of Heteroaromatic Bases. , 2016, The Journal of organic chemistry.

[9]  C Scott Shultz,et al.  Unlocking the potential of asymmetric hydrogenation at Merck. , 2007, Accounts of chemical research.

[10]  Gary A. Molander,et al.  Efficient cross-coupling of secondary alkyltrifluoroborates with aryl chlorides--reaction discovery using parallel microscale experimentation. , 2008, Journal of the American Chemical Society.

[11]  H. Tornqvist,et al.  Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial , 2014, Diabetes, obesity & metabolism.

[12]  Spencer D Dreher,et al.  Suzuki-Miyaura cross-coupling reactions of primary alkyltrifluoroborates with aryl chlorides. , 2009, The Journal of organic chemistry.

[13]  Jonas Boström,et al.  Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? , 2016, Journal of medicinal chemistry.

[14]  Bing Li,et al.  Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc04751j , 2016, Chemical science.

[15]  T. Cernak.  Synthesis in the Chemical Space Age , 2016 .

[16]  I. Davies,et al.  P2Et Phosphazene: A Mild, Functional Group Tolerant Base for Soluble, Room Temperature Pd-Catalyzed C-N, C-O, and C-C Cross-Coupling Reactions. , 2015, Organic letters.

[17]  Tim Cernak,et al.  The medicinal chemist's toolbox for late stage functionalization of drug-like molecules. , 2016, Chemical Society reviews.

[18]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[19]  Shane W. Krska,et al.  Late-stage functionalization of biologically active heterocycles through photoredox catalysis. , 2014, Angewandte Chemie.

[20]  S. Watkins,et al.  Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[21]  Adam Nelson,et al.  A unified lead-oriented synthesis of over fifty molecular scaffolds. , 2015, Organic & biomolecular chemistry.

[22]  Shirly Pinto,et al.  Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety. , 2014, ACS medicinal chemistry letters.

[23]  Adam Nelson,et al.  Towards the realisation of lead-oriented synthesis. , 2014, Drug discovery today.

[24]  Nicholas Murray Thomson,et al.  Pharmaceutical process chemistry: evolution of a contemporary data-rich laboratory environment. , 2015, The Journal of organic chemistry.

[25]  Frank Glorius,et al.  Contemporary screening approaches to reaction discovery and development. , 2014, Nature chemistry.

[26]  J. Lachowicz,et al.  Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors. , 2014, ACS medicinal chemistry letters.

[27]  Chiehying Y Chang,et al.  Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase. , 2007, Bioorganic & medicinal chemistry letters.

[28]  R. A. Thompson,et al.  Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle. , 2012, Drug discovery today.

[29]  Mirlinda Biba,et al.  MISER chiral supercritical fluid chromatography for high throughput analysis of enantiopurity. , 2016, Journal of chromatography. A.

[30]  P. Beaulieu,et al.  A Practical Oxone®-Mediated, High-Throughput, Solution-Phase Synthesis of Benzimidazoles from 1,2-Phenylenediamines and Aldehydes and its Application to Preparative Scale Synthesis , 2003 .

[31]  D. Gaudet,et al.  The DGAT1 Inhibitor LCQ908 Decreases Triglyceride Levels in Patients with the Familial Chylomicronemia Syndrome , 2012 .

[32]  G. Molander,et al.  Palladium-catalyzed, direct boronic acid synthesis from aryl chlorides: a simplified route to diverse boronate ester derivatives. , 2010, Journal of the American Chemical Society.

[33]  Shirly Pinto,et al.  Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety. , 2013, ACS medicinal chemistry letters.

[34]  R. DeVita,et al.  Synthesis of oxaspiropiperidines as a strategy for lowering log D , 2011 .

[35]  E. Regalado,et al.  Development of a Direct Photocatalytic C-H Fluorination for the Preparative Synthesis of Odanacatib. , 2015, Organic letters.

[36]  C. Karlsson,et al.  Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first‐time‐in‐human single‐dose study , 2013, Diabetes, obesity & metabolism.

[37]  Kevin Bateman,et al.  Nanomole-scale high-throughput chemistry for the synthesis of complex molecules , 2015, Science.

[38]  J. Murray,et al.  Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products. , 2014, Journal of medicinal chemistry.

[39]  P. Váchal,et al.  High-throughput purification platform in support of drug discovery. , 2012, ACS combinatorial science.

[40]  Frank Glorius,et al.  Intermolecular reaction screening as a tool for reaction evaluation. , 2015, Accounts of chemical research.

[41]  Rebecca T. Ruck,et al.  Enantioselective Synthesis of α-Methyl-β-cyclopropyldihydrocinnamates. , 2016, The Journal of organic chemistry.

[42]  Hyun-Sun Lee,et al.  Therapeutic Strategies for Metabolic Diseases: Small‐Molecule Diacylglycerol Acyltransferase (DGAT) Inhibitors , 2014, ChemMedChem.

[43]  Kendall N Houk,et al.  Rapid catalyst identification for the synthesis of the pyrimidinone core of HIV integrase inhibitors. , 2012, Angewandte Chemie.

[44]  Shane W. Krska,et al.  High-throughput optimization of Ir-catalyzed C-H borylation: a tutorial for practical applications. , 2013, Journal of the American Chemical Society.

[45]  G. Robertson,et al.  Casting solvent interactions with sulfonated poly(ether ether ketone) during proton exchange membrane fabrication , 2003 .

[46]  Shirly Pinto,et al.  Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors. , 2013, Journal of medicinal chemistry.

[47]  Allan M Jordan,et al.  The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.

[48]  Frank Glorius,et al.  Accelerated Discovery in Photocatalysis using a Mechanism-Based Screening Method. , 2016, Angewandte Chemie.